| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |